Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Shares Issued: 2014-2024

Historic Shares Issued for Syndax Pharmaceuticals (SNDX) over the last 11 years, with Dec 2024 value amounting to $8.0 million.

  • Syndax Pharmaceuticals' Shares Issued rose 126.80% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year increase of 100.38%. This contributed to the annual value of $8.0 million for FY2024, which is 56.01% up from last year.
  • Latest data reveals that Syndax Pharmaceuticals reported Shares Issued of $8.0 million as of FY2024, which was up 56.01% from $5.1 million recorded in FY2023.
  • In the past 5 years, Syndax Pharmaceuticals' Shares Issued registered a high of $11.5 million during FY2022, and its lowest value of $5.1 million during FY2023.
  • Moreover, its 3-year median value for Shares Issued was $8.0 million (2024), whereas its average is $8.2 million.
  • In the last 5 years, Syndax Pharmaceuticals' Shares Issued spiked by 3,544.51% in 2020 and then tumbled by 55.41% in 2023.
  • Yearly analysis of 5 years shows Syndax Pharmaceuticals' Shares Issued stood at $6.6 million in 2020, then declined by 4.48% to $6.3 million in 2021, then spiked by 81.50% to $11.5 million in 2022, then slumped by 55.41% to $5.1 million in 2023, then soared by 56.01% to $8.0 million in 2024.